Eckert and Ziegler

Eckert & Ziegler provides complete radiopharmaceutical development and manufacturing services covering R&D, process development, scale-up, CMC, clinical and commercial manufacturing, validation, packaging and product release. They supply GMP and chemical-grade radionuclides, radiochemicals, PET/SPECT tracer materials and therapeutic isotopes for research, diagnostics and therapy.

Eckert & Ziegler manufactures hot cells, shielding systems and automated containment environments for clinical and commercial radiopharmaceutical production. Their automated platforms handle radiolabelling, radiosynthesis, formulation and analytical QC, including TLC and HPLC, for consistent, regulatory-compliant processes.

GMP facilities operate in Germany and the US, with expansion into China, enabling global clinical supply.

Eckert & Ziegler supplies emerging therapeutic isotopes, including Actinium-225 for targeted alpha therapy. They provide regulatory consulting, validation, qualification and specialised radioactive pharmaceutical packaging and shipment across more than 80 countries.